Literature DB >> 23132745

[Use of cardiac MRI in the field of electrophysiology. Present status and future aspects].

Christan Mahnkopf1, Phillip Halbfass, Oliver Turschner, Johannes Brachmann.   

Abstract

In recent years, ablation therapy has become the first-line treatment of modern electrophysiology in patients with cardiac arrhythmias. Today, cardiac magnetic resonance imaging (cMRI) is an important supportive imaging technique in the implementation of complex electrophysiological investigations and ablation therapy. In clinical routine, cMRI is used not only to generate accurate three-dimensional (3D) models of cavities of the heart but also for visualization of complex anatomical structures. The development of cMRI makes it possible to detect the underlying substrate of complex arrhythmias such as myocardial scar in patients with ventricular tachycardia or the structural remodeling of the left atrium in patients with atrial fibrillation. The opportunity of fusion of the different imaging modalities (e.g., fluoroscopy, cMRI) has become essential for the planning and the implementation of a safe ablation therapy. The possibility of direct visualization of induced lesions using cMRI after and in the long term after ablation can predict the success of therapy and detects potential complications. The continuous research in the field of cMRI and the development of MRI-compatible pacing and ablation catheters provided the basics for performing electrophysiological treatment in humans directly inside the MRI. The implementation of ablation using exact visualization of the anatomical substrate, precise catheter navigation and real-time visualization of lesions in cMRI promises to improve success rates and the safety of complex ablation treatment and may revolutionize electrophysiology in the future.

Entities:  

Mesh:

Year:  2012        PMID: 23132745     DOI: 10.1007/s00399-012-0238-2

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  27 in total

1.  Multifunctional interventional devices for MRI: a combined electrophysiology/MRI catheter.

Authors:  Robert C Susil; Christopher J Yeung; Henry R Halperin; Albert C Lardo; Ergin Atalar
Journal:  Magn Reson Med       Date:  2002-03       Impact factor: 4.668

2.  Relationship of the esophagus and aorta to the left atrium and pulmonary veins: implications for catheter ablation of atrial fibrillation.

Authors:  Ricardo C Cury; Suhny Abbara; Steven Schmidt; Zachary J Malchano; Petr Neuzil; Jiri Weichet; Maros Ferencik; Udo Hoffmann; Jeremy N Ruskin; Thomas J Brady; Vivek Y Reddy
Journal:  Heart Rhythm       Date:  2005-12       Impact factor: 6.343

3.  Head-to-head comparison of contrast-enhanced magnetic resonance imaging and electroanatomical voltage mapping to assess post-infarct scar characteristics in patients with ventricular tachycardias: real-time image integration and reversed registration.

Authors:  Adrianus P Wijnmaalen; Rob J van der Geest; Carine F B van Huls van Taxis; Hans-Marc J Siebelink; Lucia J M Kroft; Jeroen J Bax; Johan H C Reiber; Martin J Schalij; Katja Zeppenfeld
Journal:  Eur Heart J       Date:  2010-09-23       Impact factor: 29.983

4.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

5.  Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy.

Authors:  F E Marchlinski; D J Callans; C D Gottlieb; E Zado
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

6.  Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.

Authors:  Stuart J Connolly; Paul Dorian; Robin S Roberts; Michael Gent; Steven Bailin; Eric S Fain; Kevin Thorpe; Jean Champagne; Mario Talajic; Benoit Coutu; Gerian C Gronefeld; Stefan H Hohnloser
Journal:  JAMA       Date:  2006-01-11       Impact factor: 56.272

Review 7.  Technology insight: catheter ablation of the pulmonary veins in the treatment of atrial fibrillation.

Authors:  Jun Dong; Hugh Calkins
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2005-03

8.  Initial experience of assessing esophageal tissue injury and recovery using delayed-enhancement MRI after atrial fibrillation ablation.

Authors:  Troy J Badger; Yaw A Adjei-Poku; Nathan S Burgon; Saul Kalvaitis; Akram Shaaban; Daniel N Sommers; Joshua J E Blauer; Eric N Fish; Nazem Akoum; Thomas S Haslem; Eugene G Kholmovski; Rob S MacLeod; Douglas G Adler; Nassir F Marrouche
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-12

9.  Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study.

Authors:  H C M Kamphuis; J R J de Leeuw; R Derksen; R N W Hauer; J A M Winnubst
Journal:  Europace       Date:  2003-10       Impact factor: 5.214

Review 10.  Cardiovascular magnetic resonance guided electrophysiology studies.

Authors:  Aravindan Kolandaivelu; Albert C Lardo; Henry R Halperin
Journal:  J Cardiovasc Magn Reson       Date:  2009-07-06       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.